Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| R01DK132870 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | NIH |
| Sutter Health | OTHER |
| California Pacific Medical Center Research Institute | OTHER |
Not provided
Not provided
Not provided
Not provided
The purpose of the study is to test the impact of a multilevel workplace intervention (hospital-wide sales ban on sugar-sweetened beverages (SSBs) and individual-level brief counseling) on employee health.
This double-randomized controlled trial of a multilevel workplace intervention that combines an employer-sponsored sales ban on sugar-sweetened beverages (SSBs) with brief counseling to support reduced consumption will test how well each intervention works alone, whether they work better in combination than separately, and whether or not changes in SSB cravings mediate these effects. Sutter Health worksites will be randomly assigned to either a control condition or to implement a sales ban on SSBs. Within all sites, employees will be randomized to receive/not receive a brief counseling intervention focused on reducing SSB consumption. Participants will complete self-report questionnaires, give blood samples, and provide measurements of waist circumference, height, and weight. These data will be analyzed to determine the effects of the interventions, both separately and in combination.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control: No workplace SSB sales ban, no brief intervention | No Intervention | Participants receive no workplace SSB sales ban (environmental intervention) and no brief counseling intervention. | |
| Workplace SSB sales ban only | Experimental | Participants receive a workplace SSB sales ban (environmental intervention). This entails the removal of SSBs from all workplace sales outlets, replacing them with non-sugary beverage options. |
|
| Brief intervention only | Experimental | Participants receive a 20-30 minute intervention by video call, with 2 booster telephone calls. One week and one month after the initial session, participants will have 10-minute check-in/booster phone calls. |
|
| Multilevel Intervention (workplace SSB sales ban + brief intervention) | Experimental | Sales ban: Participants receive a workplace SSB sales ban (environmental intervention). This entails the removal of SSBs from all workplace sales outlets, replacing them with non-sugary beverage options. Brief Intervention: Participants receive a 20-30 minute intervention by video call, with 2 booster telephone calls. One week and one month after the initial session, participants will have 10-minute check-in/booster phone calls. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Workplace SSB sales ban | Other | Environmental Intervention. The hospital food services will replace sugary drinks with non-sugar added alternative beverages throughout the campus. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Abdominal Adiposity (Waist Circumference) | Waist circumference in centimeters (using method from Multi-Ethnic Study of Atherosclerosis). The study will measure the change between baseline and 12 month Abdominal Adiposity measurements. | Baseline and 12 Months |
| Change in Insulin Sensitivity (HOMA) | Insulin sensitivity will be calculated using the homeostatic model assessment (HOMA). The equation for HOMA is fasting insulin (microU/L) x fasting glucose (nmol/L)/22.5. The study will measure the change between baseline and 12 month HOMA. | Baseline and 12 Months |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Body Mass Index (BMI) | Body Mass Index [BMI] measured using height in centimeters and weight in kilograms to be calculated into BMI. The study will measure the change between baseline and 12 month BMI. | Baseline and 12 Months |
| Change in Quantity of SSB Consumption |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Uric Acid Levels | Blood level of Uric Acid. The study will measure the change between baseline and 12 month Uric Acid blood levels. | Baseline and 12 Months |
| Change in HbA1C Levels | Blood Level of HbA1C. The study will measure the change between baseline and 12 month HbA1C blood levels. |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Laura A Schmidt, Ph.D | University of California, San Francisco | Principal Investigator |
| Elissa Epel, Ph.D | University of California, San Francisco | Principal Investigator |
| Jamey Schmidt | Sutter Health/California Pacific Medical Center Research Institute | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sutter Health/California Pacific Medical Center Research Institute | San Francisco | California | 94115 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Jul 10, 2023 |
Not provided
The study is a double-randomized, controlled trial of 700 Sutter Health employees working at 16 hospital campuses. The hospital campuses will be randomized to sales ban or control. After screening employees at the 16 campuses for heavy SSB consumption (> 30 oz/week), the investigators will further randomize study participants to receive the brief counseling intervention or not. This will result in a balanced design of n=175 participants in each cell of a 2x2 factorial design: 1) sales ban alone; 2) behavioral counseling alone, 3) combined condition of sales ban and behavioral counseling, and 4) no intervention or control condition. This is an efficient design for testing the effects of the sales ban and brief counseling interventions plus their cross-level interaction within a context of full randomization.
Not provided
Not provided
The study is a double-randomized, controlled trial of 700 Sutter Health employees working at 16 hospital campuses. The hospital campuses will be randomized to sales ban or control. After screening employees at the 16 campuses for heavy SSB consumption (> 30 oz/week), the investigators will further randomize study participants to receive the brief counseling intervention or not.
Not provided
| Brief Intervention | Behavioral | Participants receive single-session brief intervention, which is an intervention that uses motivational interviewing, and helps participants understand amount and effect of their baseline SSB intake, identify realistic goals for reduction and overcoming obstacles. |
|
Fluid ounces of SSB consumed per day using Automated Self-Administered Dietary Assessment Tool (ASA-24) and Beverage Intake Questionnaire (BEV-Q). The study will measure the change between baseline and 12 month SSB consumption quantity. |
| Baseline and 12 Months |
| Change in Lipid Profile Measurements | HDL, LDL, total cholesterol, triglycerides, and triglycerides:HDL ratio (calculated). The study will measure the change between baseline and 12 month individual lipid profile measurements (E.g., HDL, LDL, total cholesterol, triglycerides, and triglycerides:HDL ratio). | Baseline and 12 Months |
| Change in ApoB Levels | Blood level of ApoB. The study will measure the change between baseline and 12 month ApoB blood levels. | Baseline and 12 Months |
| Change in Fasting insulin Levels | Fasting blood level of insulin. The study will measure the change between baseline and 12 month Fasting insulin blood levels. | Baseline and 12 Months |
| Change in Fasting Glucose Levels | Fasting blood level of glucose. The study will measure the change between baseline and 12 month Fasting Glucose blood levels. | Baseline and 12 Months |
| Baseline and 12 Months |
| Jul 21, 2023 |
| Prot_SAP_000.pdf |
| ICF | No | No | Yes | Informed Consent Form | Jul 10, 2023 | Jul 21, 2023 | ICF_001.pdf |
| ID | Term |
|---|---|
| D056128 | Obesity, Abdominal |
| D007333 | Insulin Resistance |
| ID | Term |
|---|---|
| D009765 | Obesity |
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D001835 | Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D006946 | Hyperinsulinism |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D003419 | Crisis Intervention |
| ID | Term |
|---|---|
| D011613 | Psychotherapy |
| D004191 | Behavioral Disciplines and Activities |
Not provided
Not provided